Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioTime Inc (NYSE American:BTX)

2.33
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
2.19
Today|||52-Week Range
3.97
-35.46%
Year-to-Date

Today’s Trading

Previous close2.33
Today’s open2.30
Day’s range2.30 - 2.41
Volume1,093,601
Average volume (3 months)354,794
Market cap$295.6M
Data as of 8:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-2.94%
Earnings growth (next 5 years)--
Revenue growth (last year)-15.82%
P/E ratio5.5
Price/Sales60.68
Price/Book2.03

Competitors

 Today’s
change
Today’s
% change
GERNGeron Corp0.000.00%
EDGEEdge Therapeutics In...0.000.00%
AGENAgenus Inc0.000.00%
BLCMBellicum Pharmaceuti...0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateMarch 14, 2018
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$5.9M
Annual profit (last year)$33.6M
Net profit margin566.81%

Profile

Sector
Health Technology
Industry
Medical Specialties
Co-President, Co-CEO &
Director
Michael D. West
Co-President, Co-CEO &
Director
Adi Mohanty
Corporate headquarters
Alameda, California

Forecasts